Thrombocythemia
Also known as: Thrombocythaemia / Thrombocytosis / Thrombocytosis, unspecified / Thrombocytosis (disorder) / Thrombocytoses / Platelet count high / Platelets increased / Platelet count above reference range (finding) / Thrombocyte count increased / Increased number of platelets / Platelet count increased / Increased platelets
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00261 | Anagrelide | A platelet-reducing agent used to treat thrombocythemia, and its related complications, secondary to myeloproliferative neoplasms. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB00261 | Anagrelide | cGMP-inhibited 3',5'-cyclic phosphodiesterase A | target |
| DB00261 | Anagrelide | Cytochrome P450 1A2 | enzyme |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB12154 | Itacitinib | 2 | Completed | 1 |
| DB12154 | Itacitinib | 2 | Recruiting | 1 |
| DB08910 | Pomalidomide | 2 | Completed | 1 |
| DB00635 | Prednisone | 2 | Completed | 1 |
| DB00945 | Acetylsalicylic acid | Not Available | Completed | 1 |
| DB01005 | Hydroxyurea | Not Available | Completed | 1 |